Reviews - 5wrg mentioned but not cited (5)
- Structural Basis of SARS-CoV-2 and SARS-CoV Antibody Interactions. Gavor E, Choong YK, Er SY, Sivaraman H, Sivaraman J. Trends Immunol 41 1006-1022 (2020)
- Vimentin as a Multifaceted Player and Potential Therapeutic Target in Viral Infections. Ramos I, Stamatakis K, Oeste CL, Pérez-Sala D. Int J Mol Sci 21 E4675 (2020)
- Fight against novel coronavirus: A perspective of medicinal chemists. Amin SA, Jha T. Eur J Med Chem 201 112559 (2020)
- Human coronavirus spike protein-host receptor recognition. Guruprasad L. Prog Biophys Mol Biol 161 39-53 (2021)
- Emerging strategies on in silico drug development against COVID-19: challenges and opportunities. Yadav M, Dhagat S, Eswari JS. Eur J Pharm Sci 155 105522 (2020)
Articles - 5wrg mentioned but not cited (14)
- Cryo-electron microscopy structures of the SARS-CoV spike glycoprotein reveal a prerequisite conformational state for receptor binding. Gui M, Song W, Zhou H, Xu J, Chen S, Xiang Y, Wang X. Cell Res 27 119-129 (2017)
- Molecular docking study of potential phytochemicals and their effects on the complex of SARS-CoV2 spike protein and human ACE2. Basu A, Sarkar A, Maulik U. Sci Rep 10 17699 (2020)
- COVID-19: viral-host interactome analyzed by network based-approach model to study pathogenesis of SARS-CoV-2 infection. Messina F, Giombini E, Agrati C, Vairo F, Ascoli Bartoli T, Al Moghazi S, Piacentini M, Locatelli F, Kobinger G, Maeurer M, Zumla A, Capobianchi MR, Lauria FN, Ippolito G, COVID 19 INMI Network Medicine for IDs Study Group. J Transl Med 18 233 (2020)
- Different residues in the SARS-CoV spike protein determine cleavage and activation by the host cell protease TMPRSS2. Reinke LM, Spiegel M, Plegge T, Hartleib A, Nehlmeier I, Gierer S, Hoffmann M, Hofmann-Winkler H, Winkler M, Pöhlmann S. PLoS One 12 e0179177 (2017)
- Molecular Mechanisms Behind Anti SARS-CoV-2 Action of Lactoferrin. Miotto M, Di Rienzo L, Bò L, Boffi A, Ruocco G, Milanetti E. Front Mol Biosci 8 607443 (2021)
- Molecular Investigation of SARS-CoV-2 Proteins and Their Interactions with Antiviral Drugs. Calligari P, Bobone S, Ricci G, Bocedi A. Viruses 12 (2020)
- Why are ACE2 binding coronavirus strains SARS-CoV/SARS-CoV-2 wild and NL63 mild? Rawat P, Jemimah S, Ponnuswamy PK, Gromiha MM. Proteins 89 389-398 (2021)
- Exploring the Association Between Sialic Acid and SARS-CoV-2 Spike Protein Through a Molecular Dynamics-Based Approach. Bò L, Miotto M, Di Rienzo L, Milanetti E, Ruocco G. Front Med Technol 2 614652 (2020)
- Discovery of Small Molecule Entry Inhibitors Targeting the Fusion Peptide of SARS-CoV-2 Spike Protein. Hu X, Chen CZ, Xu M, Hu Z, Guo H, Itkin Z, Shinn P, Ivin P, Leek M, Liang TJ, Shen M, Zheng W, Hall MD. ACS Med Chem Lett 12 1267-1274 (2021)
- Eltrombopag is a potential target for drug intervention in SARS-CoV-2 spike protein. Feng S, Luan X, Wang Y, Wang H, Zhang Z, Wang Y, Tian Z, Liu M, Xiao Y, Zhao Y, Zhou R, Zhang S. Infect Genet Evol 85 104419 (2020)
- Phytochemicals as potential drug candidates for targeting SARS CoV 2 proteins, an in silico study. Nag A, Banerjee R, Chowdhury RR, Krishnapura Venkatesh C. Virusdisease 32 98-107 (2021)
- Structure and Mutations of SARS-CoV-2 Spike Protein: A Focused Overview. Mehra R, Kepp KP. ACS Infect Dis 8 29-58 (2022)
- Detection of Coronaviruses in Bats in Lebanon during 2020. Kandeil A, Abi-Said M, Badra R, El-Shesheny R, Al-Karmalawy AA, Alnajjar R, Khalid Z, Kamel MN, Abi Habib W, Abdallah J, Dhanasekaran V, Webby R, Kayali G. Pathogens 12 876 (2023)
- Letter Plant phytochemicals as potential candidates for treating post-COVID-19 lung infections. Zeyad Bazbouz L, Ghassan Ibrahim F, Lakshmi Chelakkot A, Matar R, Merheb M, Hodeify R, Vazhappilly CG. Phytother Res 37 383-387 (2023)
Reviews citing this publication (106)
- The deadly coronaviruses: The 2003 SARS pandemic and the 2020 novel coronavirus epidemic in China. Yang Y, Peng F, Wang R, Yange, Guan K, Jiang T, Xu G, Sun J, Chang C. J Autoimmun 109 102434 (2020)
- SARS-CoV-2/COVID-19 and advances in developing potential therapeutics and vaccines to counter this emerging pandemic. Rabaan AA, Al-Ahmed SH, Sah R, Tiwari R, Yatoo MI, Patel SK, Pathak M, Malik YS, Dhama K, Singh KP, Bonilla-Aldana DK, Haque S, Martinez-Pulgarin DF, Rodriguez-Morales AJ, Leblebicioglu H. Ann Clin Microbiol Antimicrob 19 40 (2020)
- Coronavirus membrane fusion mechanism offers a potential target for antiviral development. Tang T, Bidon M, Jaimes JA, Whittaker GR, Daniel S. Antiviral Res 178 104792 (2020)
- Physiological and molecular triggers for SARS-CoV membrane fusion and entry into host cells. Millet JK, Whittaker GR. Virology 517 3-8 (2018)
- Membrane binding proteins of coronaviruses. J Alsaadi EA, Jones IM. Future Virol 14 275-286 (2019)
- Molecular mechanism of interaction between SARS-CoV-2 and host cells and interventional therapy. Zhang Q, Xiang R, Huo S, Zhou Y, Jiang S, Wang Q, Yu F. Signal Transduct Target Ther 6 233 (2021)
- Structural and functional properties of SARS-CoV-2 spike protein: potential antivirus drug development for COVID-19. Huang Y, Yang C, Xu XF, Xu W, Liu SW. Acta Pharmacol Sin 41 1141-1149 (2020)
- Molecular diversity of coronavirus host cell entry receptors. Millet JK, Jaimes JA, Whittaker GR. FEMS Microbiol Rev 45 fuaa057 (2021)
- COVID-19 Coronavirus spike protein analysis for synthetic vaccines, a peptidomimetic antagonist, and therapeutic drugs, and analysis of a proposed achilles' heel conserved region to minimize probability of escape mutations and drug resistance. Robson B. Comput Biol Med 121 103749 (2020)
- Perspectives in Peptide-Based Vaccination Strategies for Syndrome Coronavirus 2 Pandemic. Di Natale C, La Manna S, De Benedictis I, Brandi P, Marasco D. Front Pharmacol 11 578382 (2020)
- Dietary Supplements and Nutraceuticals under Investigation for COVID-19 Prevention and Treatment. Lordan R, Rando HM, COVID-19 Review Consortium, Greene CS. mSystems 6 e00122-21 (2021)
- Structural Evaluation of the Spike Glycoprotein Variants on SARS-CoV-2 Transmission and Immune Evasion. Salleh MZ, Derrick JP, Deris ZZ. Int J Mol Sci 22 7425 (2021)
- Minireview of progress in the structural study of SARS-CoV-2 proteins. Zhu G, Zhu C, Zhu Y, Sun F. Curr Res Microb Sci 1 53-61 (2020)
- SARS-CoV-2, Early Entry Events. Chambers JP, Yu J, Valdes JJ, Arulanandam BP. J Pathog 2020 9238696 (2020)
- Mucin signature as a potential tool to predict susceptibility to COVID-19. Bose M, Mitra B, Mukherjee P. Physiol Rep 9 e14701 (2021)
- Role of host factors in SARS-CoV-2 entry. Evans JP, Liu SL. J Biol Chem 297 100847 (2021)
- Why Is COVID-19 More Severe in Patients With Diabetes? The Role of Angiotensin-Converting Enzyme 2, Endothelial Dysfunction and the Immunoinflammatory System. Roberts J, Pritchard AL, Treweeke AT, Rossi AG, Brace N, Cahill P, MacRury SM, Wei J, Megson IL. Front Cardiovasc Med 7 629933 (2020)
- Glycans of SARS-CoV-2 Spike Protein in Virus Infection and Antibody Production. Zhao X, Chen H, Wang H. Front Mol Biosci 8 629873 (2021)
- Spike Glycoprotein-Mediated Entry of SARS Coronaviruses. Wang L, Xiang Y. Viruses 12 E1289 (2020)
- COVID-19 Genetic and Environmental Risk Factors: A Look at the Evidence. Abdelzaher H, Saleh BM, Ismail HA, Hafiz M, Gabal MA, Mahmoud M, Hashish S, Gawad RMA, Gharieb RY, Abdelnaser A. Front Pharmacol 11 579415 (2020)
- Coronavirus in human diseases: Mechanisms and advances in clinical treatment. Lin P, Wang M, Wei Y, Kim T, Wei X. MedComm (2020) 1 270-301 (2020)
- The taxonomy, host range and pathogenicity of coronaviruses and other viruses in the Nidovirales order. Zhou Z, Qiu Y, Ge X. Anim Dis 1 5 (2021)
- Structure and Function of Major SARS-CoV-2 and SARS-CoV Proteins. Gorkhali R, Koirala P, Rijal S, Mainali A, Baral A, Bhattarai HK. Bioinform Biol Insights 15 11779322211025876 (2021)
- A Comprehensive Review about the Molecular Structure of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): Insights into Natural Products against COVID-19. Saied EM, El-Maradny YA, Osman AA, Darwish AMG, Abo Nahas HH, Niedbała G, Piekutowska M, Abdel-Rahman MA, Balbool BA, Abdel-Azeem AM. Pharmaceutics 13 1759 (2021)
- Aptamers as promising nanotheranostic tools in the COVID-19 pandemic era. Dzuvor CKO, Tettey EL, Danquah MK. Wiley Interdiscip Rev Nanomed Nanobiotechnol 14 e1785 (2022)
- Novel and emerging mutations of SARS-CoV-2: Biomedical implications. Mohammadi E, Shafiee F, Shahzamani K, Ranjbar MM, Alibakhshi A, Ahangarzadeh S, Beikmohammadi L, Shariati L, Hooshmandi S, Ataei B, Javanmard SH. Biomed Pharmacother 139 111599 (2021)
- Role of SARS-CoV-2 and ACE2 variations in COVID-19. Antony P, Vijayan R. Biomed J 44 235-244 (2021)
- ACE2, TMPRSS2 distribution and extrapulmonary organ injury in patients with COVID-19. Dong M, Zhang J, Ma X, Tan J, Chen L, Liu S, Xin Y, Zhuang L. Biomed Pharmacother 131 110678 (2020)
- Inflammation Triggered by SARS-CoV-2 and ACE2 Augment Drives Multiple Organ Failure of Severe COVID-19: Molecular Mechanisms and Implications. Iwasaki M, Saito J, Zhao H, Sakamoto A, Hirota K, Ma D, Ma D. Inflammation 44 13-34 (2021)
- Mutations of SARS-CoV-2 spike protein: Implications on immune evasion and vaccine-induced immunity. Mengist HM, Kombe Kombe AJ, Mekonnen D, Abebaw A, Getachew M, Jin T. Semin Immunol 55 101533 (2021)
- Structure of SARS-CoV-2 spike protein. Zhang J, Xiao T, Cai Y, Chen B. Curr Opin Virol 50 173-182 (2021)
- The probable destructive mechanisms behind COVID-19 on male reproduction system and fertility. Moshrefi M, Ghasemi-Esmailabad S, Ali J, Findikli N, Mangoli E, Khalili MA. J Assist Reprod Genet 38 1691-1708 (2021)
- A Biochemical Perspective of the Nonstructural Proteins (NSPs) and the Spike Protein of SARS CoV-2. Yoshimoto FK. Protein J 40 260-295 (2021)
- Advances in the possible treatment of COVID-19: A review. Chibber P, Haq SA, Ahmed I, Andrabi NI, Singh G. Eur J Pharmacol 883 173372 (2020)
- Modalities and Mechanisms of Treatment for Coronavirus Disease 2019. Zuo Z, Wu T, Pan L, Zuo C, Hu Y, Luo X, Jiang L, Xia Z, Xiao X, Liu J, Ye M, Deng M. Front Pharmacol 11 583914 (2020)
- Molecular biology of the SARs-CoV-2 spike protein: A review of current knowledge. Zhu C, He G, Yin Q, Zeng L, Ye X, Shi Y, Xu W. J Med Virol 93 5729-5741 (2021)
- Molecular targets for COVID-19 drug development: Enlightening Nigerians about the pandemic and future treatment. Muhammed Y. Biosaf Health 2 210-216 (2020)
- Spike protein mediated membrane fusion during SARS-CoV-2 infection. Li X, Yuan H, Li X, Wang H. J Med Virol 95 e28212 (2023)
- The spike glycoprotein of highly pathogenic human coronaviruses: structural insights for understanding infection, evolution and inhibition. Qiao S, Zhang S, Ge J, Wang X. FEBS Open Bio 12 1602-1622 (2022)
- Transmission of SARS-CoV-2, Required Developments in Research and Associated Public Health Concerns. Khan S, Liu J, Xue M. Front Med (Lausanne) 7 310 (2020)
- COVID-2019 - A comprehensive pathology insight. Shanmugam C, Mohammed AR, Ravuri S, Luthra V, Rajagopal N, Karre S. Pathol Res Pract 216 153222 (2020)
- Functional and Regulatory Roles of Fold-Switching Proteins. Kim AK, Porter LL. Structure 29 6-14 (2021)
- Mechanistic insights of host cell fusion of SARS-CoV-1 and SARS-CoV-2 from atomic resolution structure and membrane dynamics. Chakraborty H, Bhattacharjya S. Biophys Chem 265 106438 (2020)
- Molecular Virology of SARS-CoV-2 and Related Coronaviruses. Kung YA, Lee KM, Chiang HJ, Huang SY, Wu CJ, Shih SR. Microbiol Mol Biol Rev 86 e0002621 (2022)
- Point-of-Care Diagnostics of COVID-19: From Current Work to Future Perspectives. Hussein HA, Hassan RYA, Chino M, Febbraio F. Sensors (Basel) 20 (2020)
- SARS-CoV-2 and pathological matrix remodeling mediators. Guizani I, Fourti N, Zidi W, Feki M, Allal-Elasmi M. Inflamm Res 70 847-858 (2021)
- The Development of SARS-CoV-2 Variants: The Gene Makes the Disease. Perez-Gomez R. J Dev Biol 9 58 (2021)
- Thrombosis formation after COVID-19 vaccination Immunological Aspects: Review article. Waggiallah HA. Saudi J Biol Sci 29 1073-1078 (2022)
- Differences and similarities between SARS-CoV and SARS-CoV-2: spike receptor-binding domain recognition and host cell infection with support of cellular serine proteases. Rossi GA, Sacco O, Mancino E, Cristiani L, Midulla F. Infection 48 665-669 (2020)
- Involvement of sialoglycans in SARS-COV-2 infection: Opportunities and challenges for glyco-based inhibitors. Kuhaudomlarp S, Imberty A. IUBMB Life 74 1253-1263 (2022)
- Vaccines against SARS-CoV-2 variants and future pandemics. Park T, Hwang H, Moon S, Kang SG, Song S, Kim YH, Kim H, Ko EJ, Yoon SD, Kang SM, Hwang HS. Expert Rev Vaccines 21 1363-1376 (2022)
- Analysis of the SARS-CoV-2-host protein interaction network reveals new biology and drug candidates: focus on the spike surface glycoprotein and RNA polymerase. Sokullu E, Pinard M, Gauthier MS, Coulombe B. Expert Opin Drug Discov 16 881-895 (2021)
- Antibody-mediated immunity to SARS-CoV-2 spike. Errico JM, Adams LJ, Fremont DH. Adv Immunol 154 1-69 (2022)
- COVID-19: The Disease, the Immunological Challenges, the Treatment with Pharmaceuticals and Low-Dose Ionizing Radiation. Yu J, Azzam EI, Jadhav AB, Wang Y. Cells 10 2212 (2021)
- Coronaviruses disease 2019 (COVID-19): Causative agent, mental health concerns, and potential management options. Khan S, Siddique R, Bai Q, Shabana, Liu Y, Xue M, Nabi G, Liu J. J Infect Public Health 13 1840-1844 (2020)
- DCs-based therapies: potential strategies in severe SARS-CoV-2 infection. Han J, Sun J, Zhang G, Chen H. Int J Med Sci 18 406-418 (2021)
- Gastrointestinal and Hepatic Involvement in Severe Acute Respiratory Syndrome Coronavirus 2 Infection: A Review. Ghoshal UC, Ghoshal U, Dhiman RK. J Clin Exp Hepatol 10 622-628 (2020)
- Glycan Nanostructures of Human Coronaviruses. Guo W, Lakshminarayanan H, Rodriguez-Palacios A, Salata RA, Xu K, Draz MS. Int J Nanomedicine 16 4813-4830 (2021)
- Importance of Dietary Changes During the Coronavirus Pandemic: How to Upgrade Your Immune Response. Chaari A, Bendriss G, Zakaria D, McVeigh C. Front Public Health 8 476 (2020)
- Mental health consequences of infections by coronaviruses including severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Khan S, Siddique R, Xiaoyan W, Zhang R, Nabi G, Sohail Afzal M, Liu J, Xue M. Brain Behav 11 e01901 (2021)
- Molecular and Clinical Investigation of COVID-19: From Pathogenesis and Immune Responses to Novel Diagnosis and Treatment. Kashani NR, Azadbakht J, Ehteram H, Kashani HH, Rajabi-Moghadam H, Ahmad E, Nikzad H, Hosseini ES. Front Mol Biosci 9 770775 (2022)
- Molecular mechanisms involved in pathogenicity of SARS-CoV-2: Immune evasion and implications for therapeutic strategies. Latifi-Pupovci H. Biomed Pharmacother 153 113368 (2022)
- Neurological damages in COVID-19 patients: Mechanisms and preventive interventions. Sarkar S, Karmakar S, Basu M, Ghosh P, Ghosh MK. MedComm (2020) 4 e247 (2023)
- Olfactory dysfunction as a post-infectious symptom of SARS-CoV-2 infection. Othman BA, Maulud SQ, Jalal PJ, Abdulkareem SM, Ahmed JQ, Dhawan M, Priyanka, Choudhary OP. Ann Med Surg (Lond) 75 103352 (2022)
- Research progress on coronavirus S proteins and their receptors. Yuan HW, Wen HL. Arch Virol 166 1811-1817 (2021)
- The atomic portrait of SARS-CoV-2 as captured by cryo-electron microscopy. Fertig TE, Chitoiu L, Terinte-Balcan G, Peteu VE, Marta D, Gherghiceanu M. J Cell Mol Med 26 25-34 (2022)
- The role of single-domain antibodies (or nanobodies) in SARS-CoV-2 neutralization. Zebardast A, Hosseini P, Hasanzadeh A, Latifi T. Mol Biol Rep 49 647-656 (2022)
- Three-Dimensional Visualization of Viral Structure, Entry, and Replication Underlying the Spread of SARS-CoV-2. Saville JW, Berezuk AM, Srivastava SS, Subramaniam S. Chem Rev 122 14066-14084 (2022)
- Understanding COVID-19 Pandemic: Molecular Mechanisms and Potential Therapeutic Strategies. An Evidence-Based Review. Hanna R, Dalvi S, Sălăgean T, Pop ID, Bordea IR, Benedicenti S. J Inflamm Res 14 13-56 (2021)
- Update on treatment and preventive interventions against COVID-19: an overview of potential pharmacological agents and vaccines. Xiao Y, Xu H, Guo W, Zhao Y, Luo Y, Wang M, He Z, Ding Z, Liu J, Deng L, Sha F, Ma X. Mol Biomed 1 16 (2020)
- A comparative study of human betacoronavirus spike proteins: structure, function and therapeutics. Verma J, Subbarao N. Arch Virol 166 697-714 (2021)
- A narrative review on the basic and clinical aspects of the novel SARS-CoV-2, the etiologic agent of COVID-19. Hokello J, Sharma AL, Shukla GC, Tyagi M. Ann Transl Med 8 1686 (2020)
- An unexpected biomaterial against SARS-CoV-2: Bio-polyphosphate blocks binding of the viral spike to the cell receptor. Müller WEG, Schröder HC, Neufurth M, Wang X. Mater Today (Kidlington) 51 504-524 (2021)
- Analysis of the molecular mechanism of SARS-CoV-2 antibodies. Jin D, Wei J, Sun J. Biochem Biophys Res Commun 566 45-52 (2021)
- Antibodies and vaccines against Middle East respiratory syndrome coronavirus. Xu J, Jia W, Wang P, Zhang S, Shi X, Wang X, Zhang L. Emerg Microbes Infect 8 841-856 (2019)
- Biomedical nanoparticle design: What we can learn from viruses. Maslanka Figueroa S, Fleischmann D, Goepferich A. J Control Release 329 552-569 (2021)
- COVID-19 endocrinopathy with hindsight from SARS. Kothandaraman N, Rengaraj A, Xue B, Yew WS, Velan SS, Karnani N, Leow MKS. Am J Physiol Endocrinol Metab 320 E139-E150 (2021)
- COVID-19 outbreak: history, mechanism, transmission, structural studies and therapeutics. Yesudhas D, Srivastava A, Gromiha MM. Infection (2020)
- Challenges and opportunities for antiviral monoclonal antibodies as COVID-19 therapy. Cruz-Teran C, Tiruthani K, McSweeney M, Ma A, Pickles R, Lai SK. Adv Drug Deliv Rev 169 100-117 (2021)
- Characterization of the angiotensin-converting enzyme 2 (ACE2), the main receptor for the SARS-CoV-2 virus. Jami G, Ataee M, Esmaeili V, Chamani S, Rezaei A, Naghizadeh A. Am J Clin Exp Immunol 12 24-44 (2023)
- Cryo-electron microscopy in the fight against COVID-19-mechanism of virus entry. Bodakuntla S, Kuhn CC, Biertümpfel C, Mizuno N. Front Mol Biosci 10 1252529 (2023)
- Current diagnostic and therapeutic strategies for COVID-19. Chen BB, Liu ML, Huang CZ. J Pharm Anal (2021)
- Deep learning for reconstructing protein structures from cryo-EM density maps: Recent advances and future directions. Giri N, Roy RS, Cheng J. Curr Opin Struct Biol 79 102536 (2023)
- Demystifying mRNA vaccines: an emerging platform at the forefront of cryptic diseases. Rouf NZ, Biswas S, Tarannum N, Oishee LM, Muna MM. RNA Biol 19 386-410 (2022)
- Domains and Functions of Spike Protein in Sars-Cov-2 in the Context of Vaccine Design. Xia X. Viruses 13 (2021)
- Drugs for COVID-19 Treatment: A New Challenge. Talukder P, Saha A, Roy S, Ghosh G, Roy DD, Barua S. Appl Biochem Biotechnol (2023)
- Electron Cryomicroscopy of Viruses at Near-Atomic Resolutions. Kaelber JT, Hryc CF, Chiu W. Annu Rev Virol 4 287-308 (2017)
- Global scenario, public health concerns and mitigation strategies to counter current ongoing SARS-CoV-2 / COVID-19 pandemic. Barbuddhe SB, Rawool DB, Gaonkar PP, Vergis J, Dhama K, Malik SS. Hum Vaccin Immunother 16 3023-3033 (2020)
- Gut distress and intervention via communications of SARS-CoV-2 with mucosal exposome. Moon Y. Front Public Health 11 1098774 (2023)
- Identification of host receptors for viral entry and beyond: a perspective from the spike of SARS-CoV-2. Xia X. Front Microbiol 14 1188249 (2023)
- Implication of in silico studies in the search for novel inhibitors against SARS-CoV-2. Ali F, Alom S, Shakya A, Ghosh SK, Singh UP, Bhat HR. Arch Pharm (Weinheim) 355 e2100360 (2022)
- Innate and adaptive immune response in SARS-CoV-2 infection-Current perspectives. Zhu Q, Xu Y, Wang T, Xie F. Front Immunol 13 1053437 (2022)
- Insights into the management of anorectal disease in the coronavirus 2019 disease era. Amjad W, Haider R, Malik A, Qureshi W. Therap Adv Gastroenterol 14 17562848211028117 (2021)
- Known Cellular and Receptor Interactions of Animal and Human Coronaviruses: A Review. Everest H, Stevenson-Leggett P, Bailey D, Bickerton E, Keep S. Viruses 14 351 (2022)
- Localized delivery of nanomedicine and antibodies for combating COVID-19. Tu B, Gao Y, An X, Wang H, Huang Y. Acta Pharm Sin B (2022)
- Molecular Dynamics Studies on the Structural Characteristics for the Stability Prediction of SARS-CoV-2. Choi KE, Kim JM, Rhee J, Park AK, Kim EJ, Kang NS. Int J Mol Sci 22 8714 (2021)
- Molecular characterization, pathogen-host interaction pathway and in silico approaches for vaccine design against COVID-19. Singh N, Rai SN, Singh V, Singh MP. J Chem Neuroanat 110 101874 (2020)
- Multifunctional angiotensin converting enzyme 2, the SARS-CoV-2 entry receptor, and critical appraisal of its role in acute lung injury. Oz M, Lorke DE. Biomed Pharmacother 136 111193 (2021)
- Mutations in SARS-CoV-2: Insights on structure, variants, vaccines, and biomedical interventions. Abulsoud AI, El-Husseiny HM, El-Husseiny AA, El-Mahdy HA, Ismail A, Elkhawaga SY, Khidr EG, Fathi D, Mady EA, Najda A, Algahtani M, Theyab A, Alsharif KF, Albrakati A, Bayram R, Abdel-Daim MM, Doghish AS. Biomed Pharmacother 157 113977 (2023)
- Nanoscale pathogens treated with nanomaterial-like peptides: a platform technology appropriate for future pandemics. F Nahhas A, F Nahhas A, J Webster T. Nanomedicine (Lond) 16 1237-1254 (2021)
- Next-generation nanophotonic-enabled biosensors for intelligent diagnosis of SARS-CoV-2 variants. Taha BA, Al Mashhadany Y, Al-Jubouri Q, Rashid ARBA, Luo Y, Chen Z, Rustagi S, Chaudhary V, Arsad N. Sci Total Environ 880 163333 (2023)
- PEDV: Insights and Advances into Types, Function, Structure, and Receptor Recognition. Lin F, Zhang H, Li L, Yang Y, Zou X, Chen J, Tang X. Viruses 14 1744 (2022)
- Recent progress of surface plasmon resonance in the development of coronavirus disease-2019 drug candidates. Wang Q, Liu Z. Eur J Med Chem Rep 1 100003 (2021)
- SARS-CoV-2 infection causes intestinal cell damage: Role of interferon's imbalance. Guimarães Sousa S, Kleiton de Sousa A, Maria Carvalho Pereira C, Sofia Miranda Loiola Araújo A, de Aguiar Magalhães D, Vieira de Brito T, Barbosa ALDR. Cytokine 152 155826 (2022)
- Scrutinizing Coronaviruses Using Publicly Available Bioinformatic Tools: The Viral Structural Proteins as a Case Study. Beeckmans S, Van Driessche E. Front Mol Biosci 8 671923 (2021)
- Single domain antibodies derived from ancient animals as broadly neutralizing agents for SARS-CoV-2 and other coronaviruses. Lim HT, Kok BH, Lim CP, Abdul Majeed AB, Leow CY, Leow CH. Biomed Eng Adv 4 100054 (2022)
Articles citing this publication (239)
- Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Wrapp D, Wang N, Corbett KS, Goldsmith JA, Hsieh CL, Abiona O, Graham BS, McLellan JS. Science 367 1260-1263 (2020)
- Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein. Walls AC, Park YJ, Tortorici MA, Wall A, McGuire AT, Veesler D. Cell 181 281-292.e6 (2020)
- A highly conserved cryptic epitope in the receptor binding domains of SARS-CoV-2 and SARS-CoV. Yuan M, Wu NC, Zhu X, Lee CD, So RTY, Lv H, Mok CKP, Wilson IA. Science 368 630-633 (2020)
- Cell entry mechanisms of SARS-CoV-2. Shang J, Wan Y, Luo C, Ye G, Geng Q, Auerbach A, Li F. Proc Natl Acad Sci U S A 117 11727-11734 (2020)
- Beyond Shielding: The Roles of Glycans in the SARS-CoV-2 Spike Protein. Casalino L, Gaieb Z, Goldsmith JA, Hjorth CK, Dommer AC, Harbison AM, Fogarty CA, Barros EP, Taylor BC, McLellan JS, Fadda E, Amaro RE. ACS Cent Sci 6 1722-1734 (2020)
- BA.2.12.1, BA.4 and BA.5 escape antibodies elicited by Omicron infection. Cao Y, Yisimayi A, Jian F, Song W, Xiao T, Wang L, Du S, Wang J, Li Q, Chen X, Yu Y, Wang P, Zhang Z, Liu P, An R, Hao X, Wang Y, Wang J, Feng R, Sun H, Zhao L, Zhang W, Zhao D, Zheng J, Yu L, Li C, Zhang N, Wang R, Niu X, Yang S, Song X, Chai Y, Hu Y, Shi Y, Zheng L, Li Z, Gu Q, Shao F, Huang W, Jin R, Shen Z, Wang Y, Wang X, Xiao J, Xie XS. Nature 608 593-602 (2022)
- A human monoclonal antibody blocking SARS-CoV-2 infection. Wang C, Li W, Drabek D, Okba NMA, van Haperen R, Osterhaus ADME, van Kuppeveld FJM, Haagmans BL, Grosveld F, Bosch BJ. Nat Commun 11 2251 (2020)
- Unexpected Receptor Functional Mimicry Elucidates Activation of Coronavirus Fusion. Walls AC, Xiong X, Park YJ, Tortorici MA, Snijder J, Quispe J, Cameroni E, Gopal R, Dai M, Lanzavecchia A, Zambon M, Rey FA, Corti D, Veesler D. Cell 176 1026-1039.e15 (2019)
- Controlling the SARS-CoV-2 spike glycoprotein conformation. Henderson R, Edwards RJ, Mansouri K, Janowska K, Stalls V, Gobeil SMC, Kopp M, Li D, Parks R, Hsu AL, Borgnia MJ, Haynes BF, Acharya P. Nat Struct Mol Biol 27 925-933 (2020)
- Structural insights into coronavirus entry. Tortorici MA, Veesler D. Adv Virus Res 105 93-116 (2019)
- Broad betacoronavirus neutralization by a stem helix-specific human antibody. Pinto D, Sauer MM, Czudnochowski N, Low JS, Tortorici MA, Housley MP, Noack J, Walls AC, Bowen JE, Guarino B, Rosen LE, di Iulio J, Jerak J, Kaiser H, Islam S, Jaconi S, Sprugasci N, Culap K, Abdelnabi R, Foo C, Coelmont L, Bartha I, Bianchi S, Silacci-Fregni C, Bassi J, Marzi R, Vetti E, Cassotta A, Ceschi A, Ferrari P, Cippà PE, Giannini O, Ceruti S, Garzoni C, Riva A, Benigni F, Cameroni E, Piccoli L, Pizzuto MS, Smithey M, Hong D, Telenti A, Lempp FA, Neyts J, Havenar-Daughton C, Lanzavecchia A, Sallusto F, Snell G, Virgin HW, Beltramello M, Corti D, Veesler D. Science 373 1109-1116 (2021)
- Coronavirus disease 2019 (COVID-19): current status and future perspectives. Li H, Liu SM, Yu XH, Tang SL, Tang CK. Int J Antimicrob Agents 55 105951 (2020)
- Effect of natural mutations of SARS-CoV-2 on spike structure, conformation, and antigenicity. Gobeil SM, Janowska K, McDowell S, Mansouri K, Parks R, Stalls V, Kopp MF, Manne K, Li D, Wiehe K, Saunders KO, Edwards RJ, Korber B, Haynes BF, Henderson R, Acharya P. Science 373 eabi6226 (2021)
- Selection, biophysical and structural analysis of synthetic nanobodies that effectively neutralize SARS-CoV-2. Custódio TF, Das H, Sheward DJ, Hanke L, Pazicky S, Pieprzyk J, Sorgenfrei M, Schroer MA, Gruzinov AY, Jeffries CM, Graewert MA, Svergun DI, Dobrev N, Remans K, Seeger MA, McInerney GM, Murrell B, Hällberg BM, Löw C. Nat Commun 11 5588 (2020)
- Structures of Human Antibodies Bound to SARS-CoV-2 Spike Reveal Common Epitopes and Recurrent Features of Antibodies. Barnes CO, West AP, Huey-Tubman KE, Hoffmann MAG, Sharaf NG, Hoffman PR, Koranda N, Gristick HB, Gaebler C, Muecksch F, Lorenzi JCC, Finkin S, Hägglöf T, Hurley A, Millard KG, Weisblum Y, Schmidt F, Hatziioannou T, Bieniasz PD, Caskey M, Robbiani DF, Nussenzweig MC, Bjorkman PJ. Cell 182 828-842.e16 (2020)
- Drug targets for corona virus: A systematic review. Prajapat M, Sarma P, Shekhar N, Avti P, Sinha S, Kaur H, Kumar S, Bhattacharyya A, Kumar H, Bansal S, Medhi B. Indian J Pharmacol 52 56-65 (2020)
- Cross-reactive Antibody Response between SARS-CoV-2 and SARS-CoV Infections. Lv H, Wu NC, Tsang OT, Yuan M, Perera RAPM, Leung WS, So RTY, Chan JMC, Yip GK, Chik TSH, Wang Y, Choi CYC, Lin Y, Ng WW, Zhao J, Poon LLM, Peiris JSM, Wilson IA, Mok CKP. Cell Rep 31 107725 (2020)
- Don't Overlook Digestive Symptoms in Patients With 2019 Novel Coronavirus Disease (COVID-19). Luo S, Zhang X, Xu H. Clin Gastroenterol Hepatol 18 1636-1637 (2020)
- Structural Basis for Potent Neutralization of Betacoronaviruses by Single-Domain Camelid Antibodies. Wrapp D, De Vlieger D, Corbett KS, Torres GM, Wang N, Van Breedam W, Roose K, van Schie L, VIB-CMB COVID-19 Response Team, Hoffmann M, Pöhlmann S, Graham BS, Callewaert N, Schepens B, Saelens X, McLellan JS. Cell 181 1004-1015.e15 (2020)
- Human monoclonal antibodies block the binding of SARS-CoV-2 spike protein to angiotensin converting enzyme 2 receptor. Chen X, Li R, Pan Z, Qian C, Yang Y, You R, Zhao J, Liu P, Gao L, Li Z, Huang Q, Xu L, Tang J, Tian Q, Yao W, Hu L, Yan X, Zhou X, Wu Y, Deng K, Zhang Z, Qian Z, Chen Y, Ye L. Cell Mol Immunol 17 647-649 (2020)
- Analysis of a SARS-CoV-2-Infected Individual Reveals Development of Potent Neutralizing Antibodies with Limited Somatic Mutation. Seydoux E, Homad LJ, MacCamy AJ, Parks KR, Hurlburt NK, Jennewein MF, Akins NR, Stuart AB, Wan YH, Feng J, Whaley RE, Singh S, Boeckh M, Cohen KW, McElrath MJ, Englund JA, Chu HY, Pancera M, McGuire AT, Stamatatos L. Immunity 53 98-105.e5 (2020)
- Microneedle array delivered recombinant coronavirus vaccines: Immunogenicity and rapid translational development. Kim E, Erdos G, Huang S, Kenniston TW, Balmert SC, Carey CD, Raj VS, Epperly MW, Klimstra WB, Haagmans BL, Korkmaz E, Falo LD, Gambotto A. EBioMedicine 55 102743 (2020)
- Hijacking SARS-CoV-2/ACE2 Receptor Interaction by Natural and Semi-synthetic Steroidal Agents Acting on Functional Pockets on the Receptor Binding Domain. Carino A, Moraca F, Fiorillo B, Marchianò S, Sepe V, Biagioli M, Finamore C, Bozza S, Francisci D, Distrutti E, Catalanotti B, Zampella A, Fiorucci S. Front Chem 8 572885 (2020)
- Structures and distributions of SARS-CoV-2 spike proteins on intact virions. Ke Z, Oton J, Qu K, Cortese M, Zila V, McKeane L, Nakane T, Zivanov J, Neufeldt CJ, Cerikan B, Lu JM, Peukes J, Xiong X, Kräusslich HG, Scheres SHW, Bartenschlager R, Briggs JAG. Nature 588 498-502 (2020)
- Structures of MERS-CoV spike glycoprotein in complex with sialoside attachment receptors. Park YJ, Walls AC, Wang Z, Sauer MM, Li W, Tortorici MA, Bosch BJ, DiMaio F, Veesler D. Nat Struct Mol Biol 26 1151-1157 (2019)
- Structural and Functional Analysis of the D614G SARS-CoV-2 Spike Protein Variant. Yurkovetskiy L, Wang X, Pascal KE, Tomkins-Tinch C, Nyalile TP, Wang Y, Baum A, Diehl WE, Dauphin A, Carbone C, Veinotte K, Egri SB, Schaffner SF, Lemieux JE, Munro JB, Rafique A, Barve A, Sabeti PC, Kyratsous CA, Dudkina NV, Shen K, Luban J. Cell 183 739-751.e8 (2020)
- Structural basis for broad coronavirus neutralization. Sauer MM, Tortorici MA, Park YJ, Walls AC, Homad L, Acton OJ, Bowen JE, Wang C, Xiong X, de van der Schueren W, Quispe J, Hoffstrom BG, Bosch BJ, McGuire AT, Veesler D. Nat Struct Mol Biol 28 478-486 (2021)
- Computers and viral diseases. Preliminary bioinformatics studies on the design of a synthetic vaccine and a preventative peptidomimetic antagonist against the SARS-CoV-2 (2019-nCoV, COVID-19) coronavirus. Robson B. Comput Biol Med 119 103670 (2020)
- Effect of Gastrointestinal Symptoms in Patients With COVID-19. Zhou Z, Zhao N, Shu Y, Han S, Chen B, Shu X. Gastroenterology 158 2294-2297 (2020)
- Structural Genomics of SARS-CoV-2 Indicates Evolutionary Conserved Functional Regions of Viral Proteins. Srinivasan S, Cui H, Gao Z, Liu M, Lu S, Mkandawire W, Narykov O, Sun M, Korkin D. Viruses 12 (2020)
- Clinical characteristics and outcomes of COVID-19 patients with gastrointestinal symptoms admitted to Jianghan Fangcang Shelter Hospital in Wuhan, China. Zheng T, Yang C, Wang HY, Chen X, Yu L, Wu ZL, Sun H. J Med Virol 92 2735-2741 (2020)
- In silico studies evidenced the role of structurally diverse plant secondary metabolites in reducing SARS-CoV-2 pathogenesis. Puttaswamy H, Gowtham HG, Ojha MD, Yadav A, Choudhir G, Raguraman V, Kongkham B, Selvaraju K, Shareef S, Gehlot P, Ahamed F, Chauhan L. Sci Rep 10 20584 (2020)
- The Sialoside-Binding Pocket of SARS-CoV-2 Spike Glycoprotein Structurally Resembles MERS-CoV. Awasthi M, Gulati S, Sarkar DP, Tiwari S, Kateriya S, Ranjan P, Verma SK. Viruses 12 E909 (2020)
- Glycyrrhizic acid exerts inhibitory activity against the spike protein of SARS-CoV-2. Yu S, Zhu Y, Xu J, Yao G, Zhang P, Wang M, Zhao Y, Lin G, Chen H, Chen L, Zhang J. Phytomedicine 85 153364 (2021)
- Structural basis for neutralization of SARS-CoV-2 and SARS-CoV by a potent therapeutic antibody. Lv Z, Deng YQ, Ye Q, Cao L, Sun CY, Fan C, Huang W, Sun S, Sun Y, Zhu L, Chen Q, Wang N, Nie J, Cui Z, Zhu D, Shaw N, Li XF, Li Q, Xie L, Wang Y, Rao Z, Qin CF, Wang X. Science 369 1505-1509 (2020)
- Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen. Pallesen J, Wang N, Corbett KS, Wrapp D, Kirchdoerfer RN, Turner HL, Cottrell CA, Becker MM, Wang L, Shi W, Kong WP, Andres EL, Kettenbach AN, Denison MR, Chappell JD, Graham BS, Ward AB, McLellan JS. Proc. Natl. Acad. Sci. U.S.A. 114 E7348-E7357 (2017)
- Structure of mouse coronavirus spike protein complexed with receptor reveals mechanism for viral entry. Shang J, Wan Y, Liu C, Yount B, Gully K, Yang Y, Auerbach A, Peng G, Baric R, Li F. PLoS Pathog 16 e1008392 (2020)
- Bat and pangolin coronavirus spike glycoprotein structures provide insights into SARS-CoV-2 evolution. Zhang S, Qiao S, Yu J, Zeng J, Shan S, Tian L, Lan J, Zhang L, Wang X. Nat Commun 12 1607 (2021)
- Structural Definition of a Unique Neutralization Epitope on the Receptor-Binding Domain of MERS-CoV Spike Glycoprotein. Zhang S, Zhou P, Wang P, Li Y, Jiang L, Jia W, Wang H, Fan A, Wang D, Shi X, Fang X, Hammel M, Wang S, Wang X, Zhang L. Cell Rep 24 441-452 (2018)
- A natural mutation between SARS-CoV-2 and SARS-CoV determines neutralization by a cross-reactive antibody. Wu NC, Yuan M, Bangaru S, Huang D, Zhu X, Lee CD, Turner HL, Peng L, Yang L, Burton DR, Nemazee D, Ward AB, Wilson IA. PLoS Pathog 16 e1009089 (2020)
- Identification of a repurposed drug as an inhibitor of Spike protein of human coronavirus SARS-CoV-2 by computational methods. Unni S, Aouti S, Thiyagarajan S, Padmanabhan B. J Biosci 45 130 (2020)
- A thermostable, closed SARS-CoV-2 spike protein trimer. Xiong X, Qu K, Ciazynska KA, Hosmillo M, Carter AP, Ebrahimi S, Ke Z, Scheres SHW, Bergamaschi L, Grice GL, Zhang Y, CITIID-NIHR COVID-19 BioResource Collaboration, Nathan JA, Baker S, James LC, Baxendale HE, Goodfellow I, Doffinger R, Briggs JAG. Nat Struct Mol Biol 27 934-941 (2020)
- Genomic Analysis of Early SARS-CoV-2 Variants Introduced in Mexico. Taboada B, Vazquez-Perez JA, Muñoz-Medina JE, Ramos-Cervantes P, Escalera-Zamudio M, Boukadida C, Sanchez-Flores A, Isa P, Mendieta-Condado E, Martínez-Orozco JA, Becerril-Vargas E, Salas-Hernández J, Grande R, González-Torres C, Gaytán-Cervantes FJ, Vazquez G, Pulido F, Araiza-Rodríguez A, Garcés-Ayala F, González-Bonilla CR, Grajales-Muñiz C, Borja-Aburto VH, Barrera-Badillo G, López S, Hernández-Rivas L, Perez-Padilla R, López-Martínez I, Ávila-Ríos S, Ruiz-Palacios G, Ramírez-González JE, Arias CF. J Virol 94 e01056-20 (2020)
- Isolation of a human monoclonal antibody specific for the receptor binding domain of SARS-CoV-2 using a competitive phage biopanning strategy. Zeng X, Li L, Lin J, Li X, Liu B, Kong Y, Zeng S, Du J, Xiao H, Zhang T, Zhang S, Liu J. Antib Ther 3 95-100 (2020)
- Prior and novel coronaviruses, Coronavirus Disease 2019 (COVID-19), and human reproduction: what is known? Segars J, Katler Q, McQueen DB, Kotlyar A, Glenn T, Knight Z, Feinberg EC, Taylor HS, Toner JP, Kawwass JF, American Society for Reproductive Medicine Coronavirus/COVID-19 Task Force. Fertil Steril 113 1140-1149 (2020)
- Interaction of Human ACE2 to Membrane-Bound SARS-CoV-1 and SARS-CoV-2 S Glycoproteins. Anand SP, Chen Y, Prévost J, Gasser R, Beaudoin-Bussières G, Abrams CF, Pazgier M, Finzi A. Viruses 12 E1104 (2020)
- Molecular Mechanism of Evolution and Human Infection with SARS-CoV-2. He J, Tao H, Yan Y, Huang SY, Xiao Y. Viruses 12 (2020)
- SARS-CoV-2 Fusion Peptide has a Greater Membrane Perturbating Effect than SARS-CoV with Highly Specific Dependence on Ca2. Lai AL, Freed JH. J Mol Biol 433 166946 (2021)
- Overcoming Culture Restriction for SARS-CoV-2 in Human Cells Facilitates the Screening of Compounds Inhibiting Viral Replication. Ramirez S, Fernandez-Antunez C, Galli A, Underwood A, Pham LV, Ryberg LA, Feng S, Pedersen MS, Mikkelsen LS, Belouzard S, Dubuisson J, Sølund C, Weis N, Gottwein JM, Fahnøe U, Bukh J. Antimicrob Agents Chemother 65 e0009721 (2021)
- Receptor binding and priming of the spike protein of SARS-CoV-2 for membrane fusion. Benton DJ, Wrobel AG, Xu P, Roustan C, Martin SR, Rosenthal PB, Skehel JJ, Gamblin SJ. Nature 588 327-330 (2020)
- Ca2+-dependent mechanism of membrane insertion and destabilization by the SARS-CoV-2 fusion peptide. Khelashvili G, Plante A, Doktorova M, Weinstein H. Biophys J 120 1105-1119 (2021)
- Coevolution, Dynamics and Allostery Conspire in Shaping Cooperative Binding and Signal Transmission of the SARS-CoV-2 Spike Protein with Human Angiotensin-Converting Enzyme 2. Verkhivker G. Int J Mol Sci 21 E8268 (2020)
- Feline coronavirus: Insights into viral pathogenesis based on the spike protein structure and function. Jaimes JA, Whittaker GR. Virology 517 108-121 (2018)
- Comparative Perturbation-Based Modeling of the SARS-CoV-2 Spike Protein Binding with Host Receptor and Neutralizing Antibodies: Structurally Adaptable Allosteric Communication Hotspots Define Spike Sites Targeted by Global Circulating Mutations. Verkhivker GM, Agajanian S, Oztas DY, Gupta G. Biochemistry 60 1459-1484 (2021)
- Structural dynamics of SARS-CoV-2 variants: A health monitoring strategy for anticipating Covid-19 outbreaks. Fantini J, Yahi N, Azzaz F, Chahinian H. J Infect 83 197-206 (2021)
- Exploring the genomic and proteomic variations of SARS-CoV-2 spike glycoprotein: A computational biology approach. Lokman SM, Rasheduzzaman M, Salauddin A, Barua R, Tanzina AY, Rumi MH, Hossain MI, Siddiki AMAMZ, Mannan A, Hasan MM. Infect Genet Evol 84 104389 (2020)
- Integrated Biophysical Modeling of the SARS-CoV-2 Spike Protein Binding and Allosteric Interactions with Antibodies. Verkhivker GM, Di Paola L. J Phys Chem B 125 4596-4619 (2021)
- Structural insights into the cross-neutralization of SARS-CoV and SARS-CoV-2 by the human monoclonal antibody 47D11. Fedry J, Hurdiss DL, Wang C, Li W, Obal G, Drulyte I, Du W, Howes SC, van Kuppeveld FJM, Förster F, Bosch BJ. Sci Adv 7 eabf5632 (2021)
- Free Energy Landscapes from SARS-CoV-2 Spike Glycoprotein Simulations Suggest that RBD Opening Can Be Modulated via Interactions in an Allosteric Pocket. Fallon L, Belfon KAA, Raguette L, Wang Y, Stepanenko D, Cuomo A, Guerra J, Budhan S, Varghese S, Corbo CP, Rizzo RC, Simmerling C. J Am Chem Soc 143 11349-11360 (2021)
- Cryo-EM analysis of the post-fusion structure of the SARS-CoV spike glycoprotein. Fan X, Cao D, Kong L, Zhang X. Nat Commun 11 3618 (2020)
- Distinct Roles for Sialoside and Protein Receptors in Coronavirus Infection. Qing E, Hantak M, Perlman S, Gallagher T. mBio 11 (2020)
- Importance of Neutralizing Monoclonal Antibodies Targeting Multiple Antigenic Sites on the Middle East Respiratory Syndrome Coronavirus Spike Glycoprotein To Avoid Neutralization Escape. Wang L, Shi W, Chappell JD, Joyce MG, Zhang Y, Kanekiyo M, Becker MM, van Doremalen N, Fischer R, Wang N, Corbett KS, Choe M, Mason RD, Van Galen JG, Zhou T, Saunders KO, Tatti KM, Haynes LM, Kwong PD, Modjarrad K, Kong WP, McLellan JS, Denison MR, Munster VJ, Mascola JR, Graham BS. J. Virol. 92 (2018)
- Structure-guided covalent stabilization of coronavirus spike glycoprotein trimers in the closed conformation. McCallum M, Walls AC, Bowen JE, Corti D, Veesler D. Nat Struct Mol Biol 27 942-949 (2020)
- A novel neutralizing monoclonal antibody targeting the N-terminal domain of the MERS-CoV spike protein. Chen Y, Lu S, Jia H, Deng Y, Zhou J, Huang B, Yu Y, Lan J, Wang W, Lou Y, Qin K, Tan W. Emerg Microbes Infect 6 e37 (2017)
- Characterizations of SARS-CoV-2 mutational profile, spike protein stability and viral transmission. Laha S, Chakraborty J, Das S, Manna SK, Biswas S, Chatterjee R. Infect Genet Evol 85 104445 (2020)
- Persisting Salivary IgG Against SARS-CoV-2 at 9 Months After Mild COVID-19: A Complementary Approach to Population Surveys. Alkharaan H, Bayati S, Hellström C, Aleman S, Olsson A, Lindahl K, Bogdanovic G, Healy K, Tsilingaridis G, De Palma P, Hober S, Månberg A, Nilsson P, Pin E, Sällberg Chen M. J Infect Dis 224 407-414 (2021)
- Comparative molecular dynamics study of the receptor-binding domains in SARS-CoV-2 and SARS-CoV and the effects of mutations on the binding affinity. Rezaei S, Sefidbakht Y, Uskoković V. J Biomol Struct Dyn 40 4662-4681 (2022)
- Neutralizing Human Antibodies against Severe Acute Respiratory Syndrome Coronavirus 2 Isolated from a Human Synthetic Fab Phage Display Library. Kim YJ, Lee MH, Lee SR, Chung HY, Kim K, Lee TG, Kim DY. Int J Mol Sci 22 1913 (2021)
- Docking and in silico toxicity assessment of Arthrospira compounds as potential antiviral agents against SARS-CoV-2. Petit L, Vernès L, Cadoret JP. J Appl Phycol 33 1579-1602 (2021)
- Impact of COVID-19 on the Endocrine System: A Mini-review. Clarke SA, Abbara A, Dhillo WS. Endocrinology 163 bqab203 (2022)
- Lactoferrin Against SARS-CoV-2: In Vitro and In Silico Evidences. Campione E, Lanna C, Cosio T, Rosa L, Conte MP, Iacovelli F, Romeo A, Falconi M, Del Vecchio C, Franchin E, Lia MS, Minieri M, Chiaramonte C, Ciotti M, Nuccetelli M, Terrinoni A, Iannuzzi I, Coppeda L, Magrini A, Bernardini S, Sabatini S, Rosapepe F, Bartoletti PL, Moricca N, Di Lorenzo A, Andreoni M, Sarmati L, Miani A, Piscitelli P, Valenti P, Bianchi L. Front Pharmacol 12 666600 (2021)
- Tectonic conformational changes of a coronavirus spike glycoprotein promote membrane fusion. Walls AC, Tortorici MA, Snijder J, Xiong X, Bosch BJ, Rey FA, Veesler D. Proc. Natl. Acad. Sci. U.S.A. 114 11157-11162 (2017)
- Conformational dynamics of SARS-CoV-2 trimeric spike glycoprotein in complex with receptor ACE2 revealed by cryo-EM. Xu C, Wang Y, Liu C, Zhang C, Han W, Hong X, Wang Y, Hong Q, Wang S, Zhao Q, Wang Y, Yang Y, Chen K, Zheng W, Kong L, Wang F, Zuo Q, Huang Z, Cong Y. Sci Adv 7 (2021)
- Cryo-EM Structures of SARS-CoV-2 Spike without and with ACE2 Reveal a pH-Dependent Switch to Mediate Endosomal Positioning of Receptor-Binding Domains. Zhou T, Tsybovsky Y, Gorman J, Rapp M, Cerutti G, Chuang GY, Katsamba PS, Sampson JM, Schön A, Bimela J, Boyington JC, Nazzari A, Olia AS, Shi W, Sastry M, Stephens T, Stuckey J, Teng IT, Wang P, Wang S, Zhang B, Friesner RA, Ho DD, Mascola JR, Shapiro L, Kwong PD. Cell Host Microbe 28 867-879.e5 (2020)
- Distant residues modulate conformational opening in SARS-CoV-2 spike protein. Ray D, Le L, Andricioaei I. Proc Natl Acad Sci U S A 118 e2100943118 (2021)
- Dynamics of SARS-CoV-2 Spike Proteins in Cell Entry: Control Elements in the Amino-Terminal Domains. Qing E, Kicmal T, Kumar B, Hawkins GM, Timm E, Perlman S, Gallagher T. mBio 12 e0159021 (2021)
- Evolutionary and codon usage preference insights into spike glycoprotein of SARS-CoV-2. Malik YS, Ansari MI, Kattoor JJ, Kaushik R, Sircar S, Subbaiyan A, Tiwari R, Dhama K, Ghosh S, Tomar S, Zhang KYJ. Brief Bioinform 22 1006-1022 (2021)
- Plant-Produced Glycosylated and In Vivo Deglycosylated Receptor Binding Domain Proteins of SARS-CoV-2 Induce Potent Neutralizing Responses in Mice. Mamedov T, Yuksel D, Ilgın M, Gurbuzaslan I, Gulec B, Yetiskin H, Uygut MA, Islam Pavel ST, Ozdarendeli A, Mammadova G, Say D, Hasanova G. Viruses 13 1595 (2021)
- Letter A potential inhibitory role for integrin in the receptor targeting of SARS-CoV-2. Luan J, Lu Y, Gao S, Zhang L. J Infect 81 318-356 (2020)
- Biochemical Analysis of Coronavirus Spike Glycoprotein Conformational Intermediates during Membrane Fusion. Kawase M, Kataoka M, Shirato K, Matsuyama S. J Virol 93 (2019)
- Conformational flexibility and structural variability of SARS-CoV2 S protein. Pramanick I, Sengupta N, Mishra S, Pandey S, Girish N, Das A, Dutta S. Structure 29 834-845.e5 (2021)
- Deciphering the protein motion of S1 subunit in SARS-CoV-2 spike glycoprotein through integrated computational methods. Tian H, Tao P. J Biomol Struct Dyn 39 6705-6712 (2021)
- Dynamics of the ACE2-SARS-CoV-2/SARS-CoV spike protein interface reveal unique mechanisms. Ali A, Vijayan R. Sci Rep 10 14214 (2020)
- Novel human neutralizing mAbs specific for Spike-RBD of SARS-CoV-2. Passariello M, Gentile C, Ferrucci V, Sasso E, Vetrei C, Fusco G, Viscardi M, Brandi S, Cerino P, Zambrano N, Zollo M, De Lorenzo C. Sci Rep 11 11046 (2021)
- Binding mode of SARS-CoV-2 fusion peptide to human cellular membrane. Gorgun D, Lihan M, Kapoor K, Tajkhorshid E. Biophys J 120 2914-2926 (2021)
- Double lock of a potent human therapeutic monoclonal antibody against SARS-CoV-2. Zhu L, Deng YQ, Zhang RR, Cui Z, Sun CY, Fan CF, Xing X, Huang W, Chen Q, Zhang NN, Ye Q, Cao TS, Wang N, Wang L, Cao L, Wang H, Kong D, Ma J, Luo C, Zhang Y, Nie J, Sun Y, Lv Z, Shaw N, Li Q, Li XF, Hu J, Xie L, Rao Z, Wang Y, Wang X, Qin CF. Natl Sci Rev 8 nwaa297 (2021)
- Glycan Shield and Fusion Activation of a Deltacoronavirus Spike Glycoprotein Fine-Tuned for Enteric Infections. Xiong X, Tortorici MA, Snijder J, Yoshioka C, Walls AC, Li W, McGuire AT, Rey FA, Bosch BJ, Veesler D. J. Virol. 92 (2018)
- Highly Conserved Homotrimer Cavity Formed by the SARS-CoV-2 Spike Glycoprotein: A Novel Binding Site. Kalathiya U, Padariya M, Mayordomo M, Lisowska M, Nicholson J, Singh A, Baginski M, Fahraeus R, Carragher N, Ball K, Haas J, Daniels A, Hupp TR, Alfaro JA. J Clin Med 9 (2020)
- NMR structure and localization of a large fragment of the SARS-CoV fusion protein: Implications in viral cell fusion. Mahajan M, Chatterjee D, Bhuvaneswari K, Pillay S, Bhattacharjya S. Biochim Biophys Acta Biomembr 1860 407-415 (2018)
- Posttranslational modifications optimize the ability of SARS-CoV-2 spike for effective interaction with host cell receptors. Kapoor K, Chen T, Tajkhorshid E. Proc Natl Acad Sci U S A 119 e2119761119 (2022)
- SARS-CoV-2 cell receptor gene ACE2 -mediated immunomodulation in breast cancer subtypes. Bhari VK, Kumar D, Kumar S, Mishra R. Biochem Biophys Rep 24 100844 (2020)
- Spike protein recognizer receptor ACE2 targeted identification of potential natural antiviral drug candidates against SARS-CoV-2. Pokhrel S, Bouback TA, Samad A, Nur SM, Alam R, Abdullah-Al-Mamun M, Nain Z, Imon RR, Talukder MEK, Tareq MMI, Hossen MS, Karpiński TM, Ahammad F, Qadri I, Rahman MS. Int J Biol Macromol 191 1114-1125 (2021)
- Structural mapping of antibody landscapes to human betacoronavirus spike proteins. Bangaru S, Antanasijevic A, Kose N, Sewall LM, Jackson AM, Suryadevara N, Zhan X, Torres JL, Copps J, de la Peña AT, Crowe JE, Ward AB. Sci Adv 8 eabn2911 (2022)
- Structure and function analysis of a potent human neutralizing antibody CA521FALA against SARS-CoV-2. Song D, Wang W, Dong C, Ning Z, Liu X, Liu C, Du G, Sha C, Wang K, Lu J, Sun B, Zhao Y, Wang Q, Xu H, Li Y, Shen Z, Jiao J, Wang R, Tian J, Liu W, Wang L, Deng YQ, Dou C. Commun Biol 4 500 (2021)
- Anchor-Locker Binding Mechanism of the Coronavirus Spike Protein to Human ACE2: Insights from Computational Analysis. Cong Y, Feng Y, Ni H, Zhi F, Miao Y, Fang B, Zhang L, Zhang JZH. J Chem Inf Model 61 3529-3542 (2021)
- Bioinformatics analysis of epitope-based vaccine design against the novel SARS-CoV-2. Chen HZ, Tang LL, Yu XL, Zhou J, Chang YF, Wu X. Infect Dis Poverty 9 88 (2020)
- DisCoVering potential candidates of RNAi-based therapy for COVID-19 using computational methods. Rohani N, Ahmadi Moughari F, Eslahchi C. PeerJ 9 e10505 (2021)
- Discovery of Clioquinol and analogues as novel inhibitors of Severe Acute Respiratory Syndrome Coronavirus 2 infection, ACE2 and ACE2 - Spike protein interaction in vitro. Olaleye OA, Kaur M, Onyenaka C, Adebusuyi T. Heliyon 7 e06426 (2021)
- Discovery of a AHR pelargonidin agonist that counter-regulates Ace2 expression and attenuates ACE2-SARS-CoV-2 interaction. Biagioli M, Marchianò S, Roselli R, Di Giorgio C, Bellini R, Bordoni M, Gidari A, Sabbatini S, Francisci D, Fiorillo B, Catalanotti B, Distrutti E, Carino A, Zampella A, Costantino G, Fiorucci S. Biochem Pharmacol 188 114564 (2021)
- Discovery of potential small molecular SARS-CoV-2 entry blockers targeting the spike protein. Wang L, Wu Y, Yao S, Ge H, Zhu Y, Chen K, Chen WZ, Zhang Y, Zhu W, Wang HY, Guo Y, Ma PX, Ren PX, Zhang XL, Li HQ, Ali MA, Xu WQ, Jiang HL, Zhang LK, Zhu LL, Ye Y, Shang WJ, Bai F. Acta Pharmacol Sin 43 788-796 (2022)
- Epitope Profiling Reveals the Critical Antigenic Determinants in SARS-CoV-2 RBD-Based Antigen. Jiang M, Zhang G, Liu H, Ding P, Liu Y, Tian Y, Wang Y, Wang A. Front Immunol 12 707977 (2021)
- Insertion-and-Deletion Mutations between the Genomes of SARS-CoV, SARS-CoV-2, and Bat Coronavirus RaTG13. Akaishi T. Microbiol Spectr 10 e0071622 (2022)
- Landscape-Based Mutational Sensitivity Cartography and Network Community Analysis of the SARS-CoV-2 Spike Protein Structures: Quantifying Functional Effects of the Circulating D614G Variant. Verkhivker GM, Agajanian S, Oztas DY, Gupta G. ACS Omega 6 16216-16233 (2021)
- Lipidation increases antiviral activities of coronavirus fusion-inhibiting peptides. Park JE, Gallagher T. Virology 511 9-18 (2017)
- Mutations in membrane-fusion subunit of spike glycoprotein play crucial role in the recent outbreak of COVID-19. Podder S, Ghosh A, Ghosh T. J Med Virol 93 2790-2798 (2021)
- Progressive membrane-binding mechanism of SARS-CoV-2 variant spike proteins. Overduin M, Kervin TA, Tran A. iScience 25 104722 (2022)
- In silico screening of known small molecules to bind ACE2 specific RBD on Spike glycoprotein of SARS-CoV-2 for repurposing against COVID-19. Br B, Damle H, Ganju S, Damle L. F1000Res 9 663 (2020)
- Anosmia and ageusia associated with coronavirus infection (COVID-19) - what is known? Tanasa IA, Manciuc C, Carauleanu A, Navolan DB, Bohiltea RE, Nemescu D. Exp Ther Med 20 2344-2347 (2020)
- Conformational Changes of the Receptor Binding Domain of SARS-CoV-2 Spike Protein and Prediction of a B-Cell Antigenic Epitope Using Structural Data. Khare S, Azevedo M, Parajuli P, Gokulan K. Front Artif Intell 4 630955 (2021)
- Cross-neutralization of RBD mutant strains of SARS-CoV-2 by convalescent patient derived antibodies. Lou Y, Zhao W, Wei H, Chu M, Chao R, Yao H, Su J, Li Y, Li X, Cao Y, Feng Y, Wang P, Xia Y, Shang Y, Li F, Ge P, Zhang X, Gao W, Song G, Du B, Liang T, Qiu Y, Liu M. Biotechnol J 16 e2100207 (2021)
- Cryo-EM structure of the SARS coronavirus spike glycoprotein in complex with its host cell receptor ACE2. Song W, Gui M, Wang X, Xiang Y. PLoS Pathog. 14 e1007236 (2018)
- Cryo-EM structures of HKU2 and SADS-CoV spike glycoproteins provide insights into coronavirus evolution. Yu J, Qiao S, Guo R, Wang X. Nat Commun 11 3070 (2020)
- D614G Mutation Alters SARS-CoV-2 Spike Conformation and Enhances Protease Cleavage at the S1/S2 Junction. Gobeil SM, Janowska K, McDowell S, Mansouri K, Parks R, Manne K, Stalls V, Kopp MF, Henderson R, Edwards RJ, Haynes BF, Acharya P. Cell Rep 34 108630 (2021)
- Genetic Variation and Evolution of the 2019 Novel Coronavirus. Dimonte S, Babakir-Mina M, Hama-Soor T, Ali S. Public Health Genomics 24 54-66 (2021)
- Immunoinformatics characterization of SARS-CoV-2 spike glycoprotein for prioritization of epitope based multivalent peptide vaccine. Ismail S, Ahmad S, Azam SS. J Mol Liq 314 113612 (2020)
- Lipid bilayer degradation induced by SARS-CoV-2 spike protein as revealed by neutron reflectometry. Luchini A, Micciulla S, Corucci G, Batchu KC, Santamaria A, Laux V, Darwish T, Russell RA, Thepaut M, Bally I, Fieschi F, Fragneto G. Sci Rep 11 14867 (2021)
- Rational design of potent anti-COVID-19 main protease drugs: An extensive multi-spectrum in silico approach. Ahmad S, Waheed Y, Ismail S, Najmi MH, Ansari JK. J Mol Liq 330 115636 (2021)
- SSSCPreds: Deep Neural Network-Based Software for the Prediction of Conformational Variability and Application to SARS-CoV-2. Izumi H, Nafie LA, Dukor RK. ACS Omega 5 30556-30567 (2020)
- Screening of inhibitors against SARS-CoV-2 spike protein and their capability to block the viral entry mechanism: A viroinformatics study. Farouk AE, Baig MH, Khan MI, Park T, Alotaibi SS, Dong JJ. Saudi J Biol Sci 28 3262-3269 (2021)
- Tackling Covid-19 using disordered-to-order transition of residues in the spike protein upon angiotensin-converting enzyme 2 binding. Yesudhas D, Srivastava A, Sekijima M, Gromiha MM. Proteins 89 1158-1166 (2021)
- The SARS-CoV Fusion Peptide Forms an Extended Bipartite Fusion Platform that Perturbs Membrane Order in a Calcium-Dependent Manner. Lai AL, Millet JK, Daniel S, Freed JH, Whittaker GR. J. Mol. Biol. 429 3875-3892 (2017)
- "Just in Time": The Role of Cryo-Electron Microscopy in Combating Recent Pandemics. Frank J. Biochemistry 60 3449-3451 (2021)
- A COVID-19 Vaccine for Dogs Prevents Reverse Zoonosis. Ga E, Won Y, Hwang J, Moon S, Yeom M, Lyoo K, Song D, Han J, Na W. Vaccines (Basel) 10 676 (2022)
- Analysis of the avian coronavirus spike protein reveals heterogeneity in the glycans present. Stevenson-Leggett P, Armstrong S, Keep S, Britton P, Bickerton E. J Gen Virol 102 (2021)
- Characterization of the interaction between recombinant porcine aminopeptidase N and spike glycoprotein of porcine epidemic diarrhea virus. Sun YG, Li R, Jiang L, Qiao S, Zhi Y, Chen XX, Xie S, Wu J, Li X, Deng R, Zhang G. Int J Biol Macromol 117 704-712 (2018)
- Comprehensive Deep Mutational Scanning Reveals the Immune-Escaping Hotspots of SARS-CoV-2 Receptor-Binding Domain Targeting Neutralizing Antibodies. Tsai KC, Lee YC, Tseng TS. Front Microbiol 12 698365 (2021)
- Cryo-electron Microscopy Structure of the Swine Acute Diarrhea Syndrome Coronavirus Spike Glycoprotein Provides Insights into Evolution of Unique Coronavirus Spike Proteins. Guan H, Wang Y, Perčulija V, Saeed AFUH, Liu Y, Li J, Jan SS, Li Y, Zhu P, Ouyang S. J Virol 94 e01301-20 (2020)
- Design and synthesis of pyrazolone-based compounds as potent blockers of SARS-CoV-2 viral entry into the host cells. Obakachi VA, Kushwaha ND, Kushwaha B, Mahlalela MC, Shinde SR, Kehinde I, Karpoormath R. J Mol Struct 1241 130665 (2021)
- Different Binding Modes of SARS-CoV-1 and SARS-CoV-2 Fusion Peptides to Cell Membranes: The Influence of Peptide Helix Length. Shen H, Wu Z, Chen L. J Phys Chem B (2022)
- Dynamic Asymmetry Exposes 2019-nCoV Prefusion Spike. Roy S, Jaiswar A, Sarkar R. J Phys Chem Lett 11 7021-7027 (2020)
- Evaluation of spike protein antigens for SARS-CoV-2 serology. Jagtap S, K R, Valloly P, Sharma R, Maurya S, Gaigore A, Ardhya C, Biligi DS, Desiraju BK, Natchu UCM, Saini DK, Roy R. J Virol Methods 296 114222 (2021)
- Identification of Antigenic Properties of Acinetobacter baumannii Proteins as Novel Putative Vaccine Candidates Using Reverse Vaccinology Approach. Piri-Gharaghie T, Doosti A, Mirzaei SA. Appl Biochem Biotechnol 194 4892-4914 (2022)
- Mechanical activation of spike fosters SARS-CoV-2 viral infection. Hu W, Zhang Y, Fei P, Zhang T, Yao D, Gao Y, Liu J, Chen H, Lu Q, Mudianto T, Zhang X, Xiao C, Ye Y, Sun Q, Zhang J, Xie Q, Wang PH, Wang J, Li Z, Lou J, Chen W. Cell Res 31 1047-1060 (2021)
- Mutational Frequencies of SARS-CoV-2 Genome during the Beginning Months of the Outbreak in USA. Kaushal N, Gupta Y, Goyal M, Khaiboullina SF, Baranwal M, Verma SC. Pathogens 9 (2020)
- Rapid 3-dimensional shape determination of globular proteins by mobility capillary electrophoresis and native mass spectrometry. Wu H, Zhang R, Zhang W, Hong J, Xiang Y, Xu W. Chem Sci 11 4758-4765 (2020)
- Site-Specific Glycosylation Patterns of the SARS-CoV-2 Spike Protein Derived From Recombinant Protein and Viral WA1 and D614G Strains. Tian Y, Parsons LM, Jankowska E, Cipollo JF. Front Chem 9 767448 (2021)
- Structural basis for human coronavirus attachment to sialic acid receptors. Tortorici MA, Walls AC, Lang Y, Wang C, Li Z, Koerhuis D, Boons GJ, Bosch BJ, Rey FA, de Groot RJ, Veesler D. Nat. Struct. Mol. Biol. 26 481-489 (2019)
- Virus database annotations assist in tracing information on patients infected with emerging pathogens. Nakashima A, Takeya M, Kuba K, Takano M, Nakashima N. Inform Med Unlocked 21 100442 (2020)
- A multi-pronged approach targeting SARS-CoV-2 proteins using ultra-large virtual screening. Gorgulla C, Padmanabha Das KM, Leigh KE, Cespugli M, Fischer PD, Wang ZF, Tesseyre G, Pandita S, Shnapir A, Calderaio A, Gechev M, Rose A, Lewis N, Hutcheson C, Yaffe E, Luxenburg R, Herce HD, Durmaz V, Halazonetis TD, Fackeldey K, Patten JJ, Chuprina A, Dziuba I, Plekhova A, Moroz Y, Radchenko D, Tarkhanova O, Yavnyuk I, Gruber C, Yust R, Payne D, Näär AM, Namchuk MN, Davey RA, Wagner G, Kinney J, Arthanari H. iScience 24 102021 (2021)
- An insight into the inhibitory mechanism of phytochemicals and FDA-approved drugs on the ACE2-Spike complex of SARS-CoV-2 using computational methods. Jani V, Koulgi S, Uppuladinne VNM, Sonavane U, Joshi R. Chem Zvesti 75 4625-4648 (2021)
- COVID-19 and Endocrine System: A Cross-Sectional Study on 60 Patients with Endocrine Abnormality. Hadisi N, Abedi H, Shokoohi M, Tasdemir S, Mamikhani SH, Meshgi SH, Zolfagharzadeh A, Roshangar L. Cell J 24 182-187 (2022)
- Correlation between gastrointestinal symptoms and disease severity in patients with COVID-19: a systematic review and meta-analysis. Liu J, Cui M, Yang T, Yao P. BMJ Open Gastroenterol 7 (2020)
- Density estimation of SARS-CoV2 spike proteins using super pixels segmentation technique. Taha BA, Al-Jubouri Q, Al Mashhadany Y, Hafiz Mokhtar MH, Bin Zan MSD, Bakar AAA, Arsad N. Appl Soft Comput 138 110210 (2023)
- Effect of Disulfide Bridge on the Binding of SARS-CoV-2 Fusion Peptide to Cell Membrane: A Coarse-Grained Study. Shen H, Wu Z. ACS Omega 7 36762-36775 (2022)
- Epitope-Based Potential Vaccine Candidate for Humoral and Cell-Mediated Immunity to Combat Severe Acute Respiratory Syndrome Coronavirus 2 Pandemic. Das BK, Chakraborty D. J Phys Chem Lett 11 9920-9930 (2020)
- Exploring the Regulatory Function of the N-terminal Domain of SARS-CoV-2 Spike Protein through Molecular Dynamics Simulation. Li Y, Wang T, Zhang J, Shao B, Gong H, Wang Y, He X, Liu S, Liu TY. Adv Theory Simul 4 2100152 (2021)
- Exploring the intrinsic dynamics of SARS-CoV-2, SARS-CoV and MERS-CoV spike glycoprotein through normal mode analysis using anisotropic network model. Majumder S, Chaudhuri D, Datta J, Giri K. J Mol Graph Model 102 107778 (2021)
- Functional role of the type 1 pilus rod structure in mediating host-pathogen interactions. Spaulding CN, Schreiber HL, Zheng W, Dodson KW, Hazen JE, Conover MS, Wang F, Svenmarker P, Luna-Rico A, Francetic O, Andersson M, Hultgren S, Egelman EH. Elife 7 (2018)
- In Silico Comparison of Separate or Combinatorial Effects of Potential Inhibitors of the SARS-CoV-2 Binding Site of ACE2. Shakhsi-Niaei M, Soureshjani EH, Babaheydari AK. Iran J Public Health 50 1028-1036 (2021)
- Insight into vaccine development for Alpha-coronaviruses based on structural and immunological analyses of spike proteins. Shi Y, Shi J, Sun L, Tan Y, Wang G, Guo F, Hu G, Fu Y, Fu ZF, Xiao S, Peng G. J Virol JVI.02284-20 (2021)
- Molecular basis of the potential interaction of SARS-CoV-2 spike protein to CD147 in COVID-19 associated-lymphopenia. Helal MA, Shouman S, Abdelwaly A, Elmehrath AO, Essawy M, Sayed SM, Saleh AH, El-Badri N. J Biomol Struct Dyn 1-11 (2020)
- Molecular markers for early stratification of disease severity and progression in COVID-19. Kashyap A, Sebastian SA, Krishnaiyer NarayanaSwamy SR, Raksha K, Krishnamurthy H, Krishna B, D'Souza G, Idiculla J, Vyas N. Biol Methods Protoc 7 bpac028 (2022)
- Prefusion spike protein stabilization through computational mutagenesis. Zhang DY, Wang J, Dokholyan NV. Proteins 89 399-408 (2021)
- Probing structural basis for enhanced binding of SARS-CoV-2 P.1 variant spike protein with the human ACE2 receptor. Lata S, Akif M. J Cell Biochem 123 1207-1221 (2022)
- Receptor-binding loops in alphacoronavirus adaptation and evolution. Wong AHM, Tomlinson ACA, Zhou D, Satkunarajah M, Chen K, Sharon C, Desforges M, Talbot PJ, Rini JM. Nat Commun 8 1735 (2017)
- SARS-CoV-2 variants impact RBD conformational dynamics and ACE2 accessibility. Valério M, Borges-Araújo L, Melo MN, Lousa D, Soares CM. Front Med Technol 4 1009451 (2022)
- Spike protein mutational landscape in India during the complete lockdown phase: Could Muller's ratchet be a future game-changer for COVID-19? Banerjee R, Basak K, Ghosh A, Rajachandran V, Sureka K, Ganguly D, Chattopadhyay S. Infect Genet Evol 92 104874 (2021)
- Stabilized coronavirus spikes are resistant to conformational changes induced by receptor recognition or proteolysis. Kirchdoerfer RN, Wang N, Pallesen J, Wrapp D, Turner HL, Cottrell CA, Corbett KS, Graham BS, McLellan JS, Ward AB. Sci Rep 8 15701 (2018)
- Structural Analysis of Biomolecules through a Combination of Mobility Capillary Electrophoresis and Mass Spectrometry. He M, Luo P, Hong J, Wang X, Wu H, Zhang R, Qu F, Xiang Y, Xu W. ACS Omega 4 2377-2386 (2019)
- Structural definition of a pan-sarbecovirus neutralizing epitope on the spike S2 subunit. Hurlburt NK, Homad LJ, Sinha I, Jennewein MF, MacCamy AJ, Wan YH, Boonyaratanakornkit J, Sholukh AM, Jackson AM, Zhou P, Burton DR, Andrabi R, Ozorowski G, Ward AB, Stamatatos L, Pancera M, McGuire AT. Commun Biol 5 342 (2022)
- The potential involvement of JAK-STAT signaling pathway in the COVID-19 infection assisted by ACE2. Luo J, Lu S, Yu M, Zhu L, Zhu C, Li C, Fang J, Zhu X, Wang X. Gene 768 145325 (2021)
- Up State of the SARS-COV-2 Spike Homotrimer Favors an Increased Virulence for New Variants. Giron CC, Laaksonen A, Barroso da Silva FL. Front Med Technol 3 694347 (2021)
- [Quantitative determination and optimun extraction technique of nine compounds of Paeoniae Radix Alba]. Feng Y, Yin L, Liu Y, Cao L, Zheng N, Li M, Zhan S. Zhejiang Da Xue Xue Bao Yi Xue Ban 49 356-363 (2020)
- A Nanomechanical Study on Deciphering the Stickiness of SARS-CoV-2 on Inanimate Surfaces. Xie L, Liu F, Liu J, Zeng H. ACS Appl Mater Interfaces 12 58360-58368 (2020)
- A Retinol Derivative Inhibits SARS-CoV-2 Infection by Interrupting Spike-Mediated Cellular Entry. Tong L, Wang L, Liao S, Xiao X, Qu J, Wu C, Zhu Y, Tai W, Huang Y, Wang P, Li L, Zhang R, Xiang Y, Cheng G. mBio 13 e0148522 (2022)
- A bias of Asparagine to Lysine mutations in SARS-CoV-2 outside the receptor binding domain affects protein flexibility. Boer JC, Pan Q, Holien JK, Nguyen TB, Ascher DB, Plebanski M. Front Immunol 13 954435 (2022)
- A potential solution to avoid overdose of mixed drugs in the event of Covid-19: Nanomedicine at the heart of the Covid-19 pandemic. Duverger E, Herlem G, Picaud F. J Mol Graph Model 104 107834 (2021)
- An integrated understanding of the evolutionary and structural features of the SARS-CoV-2 spike receptor binding domain (RBD). Sanyal D, Banerjee S, Bej A, Chowdhury VR, Uversky VN, Chowdhury S, Chattopadhyay K. Int J Biol Macromol 217 492-505 (2022)
- Analytical Ultracentrifugation Detects Quaternary Rearrangements and Antibody-Induced Conformational Selection of the SARS-CoV-2 Spike Trimer. Guerrini G, Mehn D, Fumagalli F, Gioria S, Pedotti M, Simonelli L, Bianchini F, Robbiani DF, Varani L, Calzolai L. Int J Mol Sci 24 14875 (2023)
- Analytical evaluation and critical appraisal of early commercial SARS-CoV-2 immunoassays for routine use in a diagnostic laboratory. Cramer A, Goodman N, Cross T, Gant V, Dziadzio M. Br J Biomed Sci 1-6 (2021)
- Antibody neutralization of SARS-CoV-2 through ACE2 receptor mimicry. Ge J, Wang R, Ju B, Zhang Q, Sun J, Chen P, Zhang S, Tian Y, Shan S, Cheng L, Zhou B, Song S, Zhao J, Wang H, Shi X, Ding Q, Liu L, Zhao J, Zhang Z, Wang X, Zhang L. Nat Commun 12 250 (2021)
- Antigenic mapping reveals sites of vulnerability on α-HCoV spike protein. Xiang J, Su J, Lan Q, Zhao W, Zhou Y, Xu Y, Niu J, Xia S, Qi Q, Sidhu S, Lu L, Miersch S, Yang B. Commun Biol 5 1179 (2022)
- Are Gastrointestinal Symptoms Important in Patients with COVID-19? Büküm E, Oğuz Ayarcı A, Güler K. Turk J Gastroenterol 34 203-210 (2023)
- Bioinformatics-Based Approaches to Study Virus-Host Interactions During SARS-CoV-2 Infection. Khan MS, Yousafi Q, Bibi S, Azhar M, Ihsan A. Methods Mol Biol 2452 197-212 (2022)
- Editorial COVID-19: Current status, Challenges and Future Perspectives. Prasad R. Indian J Clin Biochem 1-2 (2020)
- Capturing a Crucial 'Disorder-to-Order Transition' at the Heart of the Coronavirus Molecular Pathology-Triggered by Highly Persistent, Interchangeable Salt-Bridges. Roy S, Ghosh P, Bandyopadhyay A, Basu S. Vaccines (Basel) 10 301 (2022)
- Comparative Analysis of Nanomechanical Features of Coronavirus Spike Proteins and Correlation with Lethality and Infection Rate. Hu Y, Buehler MJ. Matter 4 265-275 (2021)
- Computational Determination of Potential Multiprotein Targeting Natural Compounds for Rational Drug Design Against SARS-COV-2. Muhseen ZT, Hameed AR, Al-Hasani HMH, Ahmad S, Li G. Molecules 26 (2021)
- Computational insights into the membrane fusion mechanism of SARS-CoV-2 at the cellular level. Wang J, Maschietto F, Guberman-Pfeffer MJ, Reiss K, Allen B, Xiong Y, Lolis E, Batista VS. Comput Struct Biotechnol J 19 5019-5028 (2021)
- Contact residue contributions to interaction energies between SARS-CoV-1 spike proteins and human ACE2 receptors. Rodriguez JH, Gupta A. Sci Rep 11 1156 (2021)
- Could SARS-CoV-2-induced lung injury be attenuated by vitamin D? Xiao D, Li X, Su X, Mu D, Qu Y. Int J Infect Dis 102 196-202 (2021)
- Cryo-EM analysis of the HCoV-229E spike glycoprotein reveals dynamic prefusion conformational changes. Song X, Shi Y, Ding W, Niu T, Sun L, Tan Y, Chen Y, Shi J, Xiong Q, Huang X, Xiao S, Zhu Y, Cheng C, Fu ZF, Liu ZJ, Peng G. Nat Commun 12 141 (2021)
- Cryoelectron microscopy structures of a human neutralizing antibody bound to MERS-CoV spike glycoprotein. Zhang S, Jia W, Zeng J, Li M, Wang Z, Zhou H, Zhang L, Wang X. Front Microbiol 13 988298 (2022)
- DNA aptamers inhibit SARS-CoV-2 spike-protein binding to hACE2 by an RBD- independent or dependent approach. Silwal AP, Thennakoon SKS, Arya SP, Postema RM, Jahan R, Phuoc CMT, Tan X. Theranostics 12 5522-5536 (2022)
- Development and structural basis of a two-MAb cocktail for treating SARS-CoV-2 infections. Zhang C, Wang Y, Zhu Y, Liu C, Gu C, Xu S, Wang Y, Zhou Y, Wang Y, Han W, Hong X, Yang Y, Zhang X, Wang T, Xu C, Hong Q, Wang S, Zhao Q, Qiao W, Zang J, Kong L, Wang F, Wang H, Qu D, Lavillette D, Tang H, Deng Q, Xie Y, Cong Y, Huang Z. Nat Commun 12 264 (2021)
- Diagnostic Performance of Three ELISAs for Detection of Antibodies against SARS-CoV-2 in Human Samples. Meira C, Silva D, Santos I, Barreto B, Rocha V, Santos E, Dos Reis B, Evangelista A, Ribeiro Dos Santos R, Machado B, Ribeiro G, Badaró R, Soares M. ScientificWorldJournal 2022 7754329 (2022)
- Disulfide stabilization reveals conserved dynamic features between SARS-CoV-1 and SARS-CoV-2 spikes. Zhang X, Li Z, Zhang Y, Liu Y, Wang J, Liu B, Chen Q, Wang Q, Fu L, Wang P, Zhong X, Jin L, Yan Q, Chen L, He J, Zhao J, Xiong X. Life Sci Alliance 6 e202201796 (2023)
- Drugs repurposing against SARS-CoV2 and the new variant B.1.1.7 (alpha strain) targeting the spike protein: molecular docking and simulation studies. Pande M, Kundu D, Srivastava R. Heliyon 7 e07803 (2021)
- Dynamic Network Modeling of Allosteric Interactions and Communication Pathways in the SARS-CoV-2 Spike Trimer Mutants: Differential Modulation of Conformational Landscapes and Signal Transmission via Cascades of Regulatory Switches. Verkhivker GM, Di Paola L. J Phys Chem B 125 850-873 (2021)
- Dynamic anti-spike protein antibody profiles in COVID-19 patients. Bao Y, Ling Y, Chen YY, Tian D, Zhao GP, Zhang XH, Hang H, Li Y, Su B, Lu HZ, Xu J, Wang Y. Int J Infect Dis 103 540-548 (2021)
- Engineering an ACE2-Derived Fragment as a Decoy for Novel SARS-CoV-2 Virus. Renzi F, Seamann A, Ganguly K, Pandey K, Byrareddy SN, Batra S, Kumar S, Ghersi D. ACS Pharmacol Transl Sci 6 857-867 (2023)
- Glycine 29 Is Critical for Conformational Changes of the Spike Glycoprotein of Mouse Hepatitis Virus A59 Triggered by either Receptor Binding or High pH. Mi D, Ou X, Li P, Peng G, Liu Y, Guo R, Mu Z, Li F, Holmes K, Qian Z. J. Virol. 93 (2019)
- Heme binding to the SARS-CoV-2 spike glycoprotein. Freeman SL, Oliveira ASF, Gallio AE, Rosa A, Simitakou MK, Arthur CJ, Mulholland AJ, Cherepanov P, Raven EL. J Biol Chem 299 105014 (2023)
- Highlight of potential impact of new viral genotypes of SARS-CoV-2 on vaccines and anti-viral therapeutics. Ghorbani A, Samarfard S, Jajarmi M, Bagheri M, Karbanowicz TP, Afsharifar A, Eskandari MH, Niazi A, Izadpanah K. Gene Rep 26 101537 (2022)
- Human coronaviruses OC43 and HKU1 bind to 9-O-acetylated sialic acids via a conserved receptor-binding site in spike protein domain A. Hulswit RJG, Lang Y, Bakkers MJG, Li W, Li Z, Schouten A, Ophorst B, van Kuppeveld FJM, Boons GJ, Bosch BJ, Huizinga EG, de Groot RJ. Proc. Natl. Acad. Sci. U.S.A. 116 2681-2690 (2019)
- Identification of Novel Linear Epitopes Located in the Infectious Bronchitis Virus Spike S2 Region. Andoh K, Ashikaga K, Suenaga K, Endo S, Yamazaki K. Avian Dis. 62 210-217 (2018)
- Identification of potential inhibitors of SARS-CoV-2 S protein-ACE2 interaction by in silico drug repurposing. Tristán-Flores FE, Casique-Aguirre D, Pliego-Arreaga R, Cervantes-Montelongo JA, García-Gutierrez P, Acosta-García G, Silva-Martínez GA. F1000Res 10 Chem Inf Sci-358 (2021)
- Immunogenicity mechanism of mRNA vaccines and their limitations in promoting adaptive protection against SARS-CoV-2. Salleh MZ, Norazmi MN, Deris ZZ. PeerJ 10 e13083 (2022)
- Immunoinformatics approach of epitope prediction for SARS-CoV-2. Awad N, Mohamed RH, Ghoneim NI, Elmehrath AO, El-Badri N. J Genet Eng Biotechnol 20 60 (2022)
- Impact of the COVID-19 vaccine booster strategy on vaccine protection: a pilot study of a military hospital in Taiwan. Wang YL, Cheng ST, Shen CF, Huang SW, Cheng CM. Clin Exp Vaccine Res 12 337-345 (2023)
- In Vitro Anti-SARS-CoV-2 Activity of Selected Metal Compounds and Potential Molecular Basis for Their Actions Based on Computational Study. Cirri D, Marzo T, Tolbatov I, Marrone A, Saladini F, Vicenti I, Dragoni F, Boccuto A, Messori L. Biomolecules 11 1858 (2021)
- Interactions of SARS-CoV-2 and MERS-CoV fusion peptides measured using single-molecule force methods. Qiu C, Whittaker GR, Gellman SH, Daniel S, Abbott NL. Biophys J 122 646-660 (2023)
- Introduction and effect of natural selection analysis at common mutations of SARS-CoV-2 spike gene in Iran. Nedaei F, Esmaeili Rastaghi AR, Goodarzi E, Haji Mullah Asadullah H, Mirhadi F, Fateh A. Virus Res 336 199202 (2023)
- Ionization of D571 Is Coupled with SARS-CoV-2 Spike Up/Down Equilibrium Revealing the pH-Dependent Allosteric Mechanism of Receptor-Binding Domains. Li T, Yu L, Sun J, Liu J, He X. J Phys Chem B 126 4828-4839 (2022)
- Kinetics of Viral Clearance and Antibody Production Across Age Groups in Children with Severe Acute Respiratory Syndrome Coronavirus 2 Infection. Bahar B, Jacquot C, Mo YD, DeBiasi RL, Campos J, Delaney M. J Pediatr 227 31-37.e1 (2020)
- Label-Free Analysis of Binding and Inhibition of SARS-Cov-19 Spike Proteins to ACE2 Receptor with ACE2-Derived Peptides by Surface Plasmon Resonance. Abouhajar F, Chaudhuri R, Valiulis SN, Stuart DD, Malinick AS, Xue M, Cheng Q. ACS Appl Bio Mater 6 182-190 (2023)
- Lys417 acts as a molecular switch that regulates the conformation of SARS-CoV-2 spike protein. Geng Q, Wan Y, Hsueh FC, Shang J, Ye G, Bu F, Herbst M, Wilkens R, Liu B, Li F. Elife 12 e74060 (2023)
- Molecular Docking and Dynamics Studies to Explore Effective Inhibitory Peptides Against the Spike Receptor Binding Domain of SARS-CoV-2. Biswas S, Mahmud S, Mita MA, Afrose S, Hasan MR, Sultana Shimu MS, Saleh MA, Mostafa-Hedeab G, Alqarni M, Obaidullah AJ, Batiha GE. Front Mol Biosci 8 791642 (2021)
- Molecular Dynamic Simulation Search for Possible Amphiphilic Drug Discovery for Covid-19. Daood U, Gopinath D, Pichika MR, Mak KK, Seow LL. Molecules 26 2214 (2021)
- Molecular Insights into the Binding Behavior of Imidazolium Ionic Liquids to the Receptor Binding Domain of the SARS-CoV-2 Spike Protein. Liu P, Li Y, Liu Y, Liu J, Dong K, Jia Q. J Phys Chem B 127 4396-4405 (2023)
- Nanomechanical analysis of SARS-CoV-2 variants and predictions of infectiousness and lethality. Hu Y, Buehler MJ. Soft Matter 18 5833-5842 (2022)
- Negatively charged residues in the membrane ordering activity of SARS-CoV-1 and -2 fusion peptides. Lai AL, Freed JH. Biophys J 121 207-227 (2022)
- New Short RNA Motifs Potentially Relevant in the SARS-CoV-2 Genome. Fuertes MA, Alonso C. Curr Genomics 23 424-440 (2023)
- Pandemic COVID-19: Current status and challenges of antiviral therapies. Chan W, He B, Wang X, He ML. Genes Dis 7 502-519 (2020)
- Potential Drug Strategies to Target Coronaviruses. Sarkar K, Sil PC. Adv Exp Med Biol 1352 111-124 (2021)
- Prefusion spike protein conformational changes are slower in SARS-CoV-2 than in SARS-CoV-1. Govind Kumar V, Ogden DS, Isu UH, Polasa A, Losey J, Moradi M. J Biol Chem 298 101814 (2022)
- Rapid, high-yield production of full-length SARS-CoV-2 spike ectodomain by transient gene expression in CHO cells. Stuible M, Gervais C, Lord-Dufour S, Perret S, L'Abbé D, Schrag J, St-Laurent G, Durocher Y. J Biotechnol 326 21-27 (2021)
- Rationally Designed ACE2-Derived Peptides Inhibit SARS-CoV-2. Larue RC, Xing E, Kenney AD, Zhang Y, Tuazon JA, Li J, Yount JS, Li PK, Sharma A. Bioconjug Chem 32 215-223 (2021)
- Role of Endolysosomes in Severe Acute Respiratory Syndrome Coronavirus-2 Infection and Coronavirus Disease 2019 Pathogenesis: Implications for Potential Treatments. Khan N, Chen X, Geiger JD. Front Pharmacol 11 595888 (2020)
- SARS-CoV spike proteins can compete for electrolytes in physiological fluids according to structure-based quantum-chemical calculations. Margiotta E, Fonseca Guerra C. Comput Theor Chem 113392 (2021)
- SARS-CoV-2-free residual proteins mediated phenotypic and metabolic changes in peripheral blood monocytic-derived macrophages in support of viral pathogenesis. Mohammad MG, Ashmawy NS, Al-Rawi AM, Abu-Qiyas A, Hamoda AM, Hamdy R, Dakalbab S, Arikat S, Salahat D, Madkour M, Soliman SSM. PLoS One 18 e0280592 (2023)
- SNHG15 aids SARS-CoV-2 entry via RABL2A. Pushparaj S, Gandikota C, Vaddadi K, Liang Y, Liu L. RNA Biol 20 539-547 (2023)
- Self-derived peptides from the SARS-CoV-2 spike glycoprotein disrupting shaping and stability of the homotrimer unit. Padariya M, Daniels A, Tait-Burkard C, Hupp T, Kalathiya U. Biomed Pharmacother 151 113190 (2022)
- Sialoglycan binding triggers spike opening in a human coronavirus. Pronker MF, Creutznacher R, Drulyte I, Hulswit RJG, Li Z, van Kuppeveld FJM, Snijder J, Lang Y, Bosch BJ, Boons GJ, Frank M, de Groot RJ, Hurdiss DL. Nature (2023)
- Spike-protein proteolytic antibodies in COVID-19 convalescent plasma contribute to SARS-CoV-2 neutralization. McConnell SA, Sachithanandham J, Mudrak NJ, Zhu X, Farhang PA, Cordero RJB, Wear MP, Shapiro JR, Park HS, Klein SL, Tobian AAR, Bloch EM, Sullivan DJ, Pekosz A, Casadevall A. Cell Chem Biol S2451-9456(23)00154-X (2023)
- SpikeScape: A Tool for Analyzing Structural Diversity in Experimental Structures of the SARS-CoV-2 Spike Glycoprotein. Stepanenko D, Budhan S, Simmerling C. J Chem Inf Model 63 1087-1092 (2023)
- Structural Definition of a Neutralization-Sensitive Epitope on the MERS-CoV S1-NTD. Wang N, Rosen O, Wang L, Turner HL, Stevens LJ, Corbett KS, Bowman CA, Pallesen J, Shi W, Zhang Y, Leung K, Kirchdoerfer RN, Becker MM, Denison MR, Chappell JD, Ward AB, Graham BS, McLellan JS. Cell Rep 28 3395-3405.e6 (2019)
- Structural definition of a neutralization epitope on the N-terminal domain of MERS-CoV spike glycoprotein. Zhou H, Chen Y, Zhang S, Niu P, Qin K, Jia W, Huang B, Zhang S, Lan J, Zhang L, Tan W, Wang X. Nat Commun 10 3068 (2019)
- Structural insights into the modulation of coronavirus spike tilting and infectivity by hinge glycans. Chmielewski D, Wilson EA, Pintilie G, Zhao P, Chen M, Schmid MF, Simmons G, Wells L, Jin J, Singharoy A, Chiu W. Nat Commun 14 7175 (2023)
- Letter Structure-based development of human antibody cocktails against SARS-CoV-2. Wang N, Sun Y, Feng R, Wang Y, Guo Y, Zhang L, Deng YQ, Wang L, Cui Z, Cao L, Zhang YJ, Li W, Zhu FC, Qin CF, Wang X. Cell Res 31 101-103 (2021)
- The 442th amino acid residue of the spike protein is critical for the adaptation to bat hosts for SARS-related coronaviruses. Li JY, Wang Q, Liao CH, Qiu Y, Ge XY. Virus Res 295 198307 (2021)
- The Spectrum of Gastrointestinal Symptoms in Patients With Coronavirus Disease-19: Predictors, Relationship With Disease Severity, and Outcome. Ghoshal UC, Ghoshal U, Mathur A, Singh RK, Nath A, Garg A, Singh D, Singh S, Singh J, Pandey A, Rai S, Vasanth S, Dhiman RK. Clin Transl Gastroenterol 11 e00259 (2020)
- The adaptation of SARS-CoV-2 to humans. Tosta E. Mem Inst Oswaldo Cruz 116 e210127 (2022)
- The human coronavirus HCoV-229E S-protein structure and receptor binding. Li Z, Tomlinson AC, Wong AH, Zhou D, Desforges M, Talbot PJ, Benlekbir S, Rubinstein JL, Rini JM. Elife 8 (2019)
- Two-Stage Recognition Mechanism of the SARS-CoV-2 Receptor-Binding Domain to Angiotensin-Converting Enzyme-2 (ACE2). Biskupek I, Gieldon A. Int J Mol Sci 25 679 (2024)
- Virtual Screening on Marine Natural Products for Discovering TMPRSS2 Inhibitors. Mahmudpour M, Nabipour I, Keshavarz M, Farrokhnia M. Front Chem 9 722633 (2021)
- Why Are Viruses Spiked? Shen C, Bradford SA. mSphere 6 e01339-20 (2021)
- [Comparative analysis of structural characteristics and epitopes in S proteins between SARS-CoV-2 and SARS-CoV]. Lun Y, Liu B, Dong W, Sun J, Pan L. Zhejiang Da Xue Xue Bao Yi Xue Ban 49 315-323 (2020)
- hACE2-Induced Allosteric Activation in SARS-CoV versus SARS-CoV-2 Spike Assemblies Revealed by Structural Dynamics. Chen C, Zhu R, Hodge EA, Díaz-Salinas MA, Nguyen A, Munro JB, Lee KK. ACS Infect Dis 9 1180-1189 (2023)